These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 18832653)

  • 1. NKT-cell help to B lymphocytes can occur independently of cognate interaction.
    Tonti E; Galli G; Malzone C; Abrignani S; Casorati G; Dellabona P
    Blood; 2009 Jan; 113(2):370-6. PubMed ID: 18832653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help.
    Tonti E; Fedeli M; Napolitano A; Iannacone M; von Andrian UH; Guidotti LG; Abrignani S; Casorati G; Dellabona P
    J Immunol; 2012 Apr; 188(7):3217-22. PubMed ID: 22379027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells.
    Qin Y; Oh S; Lim S; Shin JH; Yoon MS; Park SH
    Exp Mol Med; 2019 Oct; 51(10):1-9. PubMed ID: 31653827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK T cells provide lipid antigen-specific cognate help for B cells.
    Leadbetter EA; Brigl M; Illarionov P; Cohen N; Luteran MC; Pillai S; Besra GS; Brenner MB
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8339-44. PubMed ID: 18550809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordination between T helper cells, iNKT cells, and their follicular helper subsets in the humoral immune response against Clostridium difficile toxin B.
    Rampuria P; Lang GA; Devera TS; Gilmore C; Ballard JD; Lang ML
    J Leukoc Biol; 2017 Feb; 101(2):567-576. PubMed ID: 27566831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40L-null NKT cells provide B cell help for specific antibody responses.
    Shah HB; Joshi SK; Lang ML
    Vaccine; 2011 Nov; 29(49):9132-6. PubMed ID: 21959330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand.
    Shah HB; Joshi SK; Rampuria P; Devera TS; Lang GA; Stohl W; Lang ML
    J Immunol; 2013 Aug; 191(3):1154-63. PubMed ID: 23797666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory.
    Lang GA; Johnson AM; Devera TS; Joshi SK; Lang ML
    Int Immunol; 2011 Apr; 23(4):251-60. PubMed ID: 21398691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of splenic invariant NKT cell activation dictates localization in vivo.
    King IL; Amiel E; Tighe M; Mohrs K; Veerapen N; Besra G; Mohrs M; Leadbetter EA
    J Immunol; 2013 Jul; 191(2):572-82. PubMed ID: 23785119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
    Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
    BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
    Lang GA; Exley MA; Lang ML
    Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined proinflammatory cytokine and cognate activation of invariant natural killer T cells enhances anti-DNA antibody responses.
    Sedimbi SK; Hägglöf T; Garimella MG; Wang S; Duhlin A; Coelho A; Ingelshed K; Mondoc E; Malin SG; Holmdahl R; Lane DP; Leadbetter EA; Karlsson MCI
    Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9054-9063. PubMed ID: 32295878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses.
    Fujii SI; Yamasaki S; Sato Y; Shimizu K
    Front Immunol; 2018; 9():1267. PubMed ID: 29915600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scavenger receptors target glycolipids for natural killer T cell activation.
    Freigang S; Landais E; Zadorozhny V; Kain L; Yoshida K; Liu Y; Deng S; Palinski W; Savage PB; Bendelac A; Teyton L
    J Clin Invest; 2012 Nov; 122(11):3943-54. PubMed ID: 23064364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.
    Oleinika K; Rosser EC; Matei DE; Nistala K; Bosma A; Drozdov I; Mauri C
    Nat Commun; 2018 Feb; 9(1):684. PubMed ID: 29449556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
    Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
    Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid and α-galactosylceramide differentially regulate B cell activation in vitro and augment antibody production in vivo.
    Chen Q; Mosovsky KL; Ross AC
    Clin Vaccine Immunol; 2011 Jun; 18(6):1015-20. PubMed ID: 21471300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.